Ryll Thomas 4
4 · ImmunoGen, Inc. · Filed Nov 21, 2019
Insider Transaction Report
Form 4
ImmunoGen, Inc.IMGN
Ryll Thomas
VP, Technical Operations
Transactions
- Award
Stock Option (right to buy)
2019-11-19$3.48/sh+110,950$386,106→ 110,950 totalExercise: $3.48From: 2020-11-19Exp: 2029-11-19→ Common Stock (110,950 underlying)
Footnotes (1)
- [F1]Exercisable as to 25% of the shares on the first year anniversary of the grant, and 6.25% quarterly for the subsequent three years.